NUI Galway hosts cell and EV imaging webinar, December 10, 2020
Join AutoCRAT partners at NUI Galway as they host the webinar “Real-Time Near Infrared Fluorescence Imaging Research Tools With The Potential For Clinical Use” on December 10, 2020, at 2 pm GMT. Click here for free registration: https://attendee.gotowebinar.com/register/2047840817639953935 Fluorescence-guided surgery, [...]
AutoCRAT acknowledged by Prof Dr Bernd Giebel at ISLB conference
Prof Dr Bernd Giebel, University Hospital Essen At the virtual International Society of Liquid Biopsy (ISLB) conference on Friday, October 30th, 2020, Prof Dr Bernd Giebel of the University Medicine Essen (www.uk-essen.de) will deliver a presentation acknowledging AutoCRAT. [...]
Partner news: Valitacell selected for the Startup Creasphere health tech accelerator programme
Dr Stephanie Davies leads Valitacell’s team in AutoCRAT AutoCRAT partners, Valitacell, (www.valitacell.com) a Dublin-headquartered biotechnology SME, has been selected by as one of eleven high potential global start-ups to join the prestigious health tech accelerator programme Startup Creasphere. [...]
AutoCRAT presented at RenalToolBox ITN Workshop, Galway
Profs Mary Murphy and Frank Barry, both from NUI Galway presented aspects of AutoCRAT at a recent Marie Curie Innovative Training Network workshop hosted in Galway. Coordinator Mary Murphy's talk was entitled “Mesenchymal Stromal CellsPlastic-adherent cells that can be isolated from bone marrow, adipose, and other tissue sources. These cells have the capacity to differentiate into bone cells, cartilage cells, muscle cells and fat cells. Studies have shown MSC may have therapeutic effects through their secretome. for Modulation of Disease Progression [...]
AutoCRAT introduced by Prof Bernd Giebel, University Hospital Essen at online DGTI 2020 meeting
On September 17th, 2020, AutoCRAT PI Prof. Dr Rer. Nat. Bernd Giebel of the University Hospital Essen introduced AutoCRAT at the DGTI 2020 meeting during the DGTI/DGHO Joint Session. Bernd's talk titled "Therapeutic Potential of extracellular vesicles" was part of the Neue [...]
Panaxea will investigate the cost-effectiveness of AutoCRAT’s cell-derived osteoarthritis treatment
Our partners at Panaxea (http://panaxea.eu/) have a unique role within AutoCRAT. On the Panaxea, PI Dr Janne Mewes remarks: "We will evaluate the expected cost-effectiveness of the AutoCRAT platform in an early stage of development over the course of the [...]